Why Robinhood Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket

Shares of Robinhood Markets, Inc. (NASDAQ:HOOD) rose sharply in pre-market trading.

S&P Dow Jones Indices announced a sweeping update to its benchmarks late Friday, unveiling new additions to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600. Robinhood will replace Caesars Entertainment Inc. (NASD: CZR) in the S&P 500, effective prior to the open of trading on Monday, Sept. 22.

Robinhood shares jumped 7.4% to $108.77 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

• Eightco Holdings Inc. (NASDAQ:OCTO) shares gained 142.1% to $3.51 in pre-market trading.
• Gyrodyne, LLC (NASDAQ:GYRO) rose 82.1% to $19.48 in pre-market trading.
• Forward Industries, Inc. (NASDAQ:FORD) gained 78.8% to $29.29 in pre-market trading after gaining 10% on Friday.
• Pintec Technology Holdings Limited (NASDAQ:PT) rose 62.1% to $1.54 in pre-market trading. PINTEC announced a private placement of Class A ordinary shares in exchange of ordinary shares of ZIITECH PTY LTD.
• CDT Equity Inc. (NASDAQ:CDT) rose 45.7% to $1.72 n pre-market trading.
• Seres Therapeutics, Inc. (NASDAQ:MCRB) gained 44.8% to $28.05 in pre-market trading.
• Microbot Medical Inc. (NASDAQ:MBOT) jumped 27.3% to $4.66 in pre-market trading after gaining 9% on Friday.
• Acrivon Therapeutics, Inc. (NASDAQ:ACRV) gained 27.8% to $1.70 in pre-market trading.
• Rapport Therapeutics, Inc. (NASDAQ:RAPP) surged 26.3% to $18.13 in pre-market trading. Rapport Therapeutics will announce topline results for RAP-219 Phase 2a trial in focal onset seizures on Monday, Sept. 8.

Losers

• Citius Oncology, Inc. (NASDAQ:CTOR) dipped 25% to $1.41 in pre-market trading.
• MEI Pharma, Inc. (NASDAQ:MEIP) fell 19.3% to $3.42 in pre-market trading.
• CNFinance Holdings Limited (NYSE:CNF) fell 18.8% to $3.78 in pre-market trading after jumping 94% on Friday.
• New Era Energy & Digital, Inc. (NASDAQ:NUAI) shares dipped 17.3% to $0.3111 in pre-market trading after declining 7% on Friday.
• Summit Therapeutics Inc. (NASDAQ:SMMT) declined 17% to $21.57 in pre-market trading after the company announced the updated overall survival results from the Global Phase 3 HARMONi clinical trial of Ivonescimab in EGFR-mutated non-squamous non-small cell lung cancer.
• Twin Vee Powercats Co. (NASDAQ:VEEE) fell 15.3% to $2.40 in pre-market trading after jumping 46% on Friday.
• iSpecimen Inc. (NASDAQ:ISPC) fell 15% to $0.7262 in pre-market trading. iSpecimen shares surged 27% on Friday after the company announced it advanced its $200 million Solana-based digital asset strategy.
• Sono Group N.V. (NASDAQ:SSM) declined 15% to $12.30 in pre-market trading after dipping 34% on Friday. Sono Group announced Nasdaq uplisting approval.
• New Fortress Energy Inc. (NASDAQ:NFE) dipped 12.5% to $2.14 in pre-market trading following second-quarter results.
• Verb Technology Company, Inc. (NASDAQ:TONX) fell 11.9% to $9.45 in the pre-market trading.

Now Read This:

• Top 2 Health Care Stocks That May Plunge This Month

Photo via Shutterstock